Department of Anesthesia, Hospital Clínico Universidad de Chile, University of Chile, Santiago, Chile.
Department of Anesthesia, Maharaj Nakorn Chiang Mai Hospital, Chiang Mai University, Chiang Mai, Thailand.
Reg Anesth Pain Med. 2019 Jan;44(1):46-51. doi: 10.1136/rapm-2018-000032.
This multicenter, randomized trial compared 2, 5, and 8 mg of perineural dexamethasone for ultrasound-guided infraclavicular brachial plexus block. Our research hypothesis was that all three doses of dexamethasone would result in equivalent durations of motor block (equivalence margin=3.0 hours).
Three hundred and sixty patients undergoing upper limb surgery with ultrasound-guided infraclavicular block were randomly allocated to receive 2, 5, or 8 mg of preservative-free perineural dexamethasone. The local anesthetic agent (35 mL of lidocaine 1%-bupivacaine 0.25% with epinephrine 5 µg/mL) was identical in all subjects. Patients and operators were blinded to the dose of dexamethasone. During the performance of the block, the performance time, number of needle passes, procedural pain, and complications (vascular puncture, paresthesia) were recorded. Subsequently a blinded observer assessed the success rate (defined as a minimal sensorimotor composite score of 14 out of 16 points at 30 min), onset time as well as the incidence of surgical anesthesia (defined as the ability to complete surgery without local infiltration, supplemental blocks, intravenous opioids, or general anesthesia). Postoperatively, the blinded observer contacted patients with successful blocks to inquire about the duration of motor block, sensory block, and postoperative analgesia. The main outcome variable was the duration of motor block.
No intergroup differences were observed in terms of technical execution (performance time/number of needle passes/procedural pain complications), onset time, success rate, and surgical anesthesia. Furthermore, all three doses of dexamethasone provided similar durations of motor block (14.9-16.1 hours) and sensory block. Although 5 mg provided a longer analgesic duration than 2 mg, the difference (2.7 hours) fell within our pre-established equivalence margin (3.0 hours).
2, 5, and 8 mg of dexamethasone provide clinically equivalent sensorimotor and analgesic durations for ultrasound-guided infraclavicular block. Further trials are required to compare low (ie, 2 mg) and ultra-low (eg, 0.5-1 mg) doses of perineural dexamethasone for brachial plexus blocks.
TCTR20150624001.
本多中心、随机试验比较了超声引导锁骨下臂丛神经阻滞中使用 2mg、5mg 和 8mg 周围神经内注射用甲泼尼龙的效果。我们的研究假设是所有三种剂量的甲泼尼龙都会导致等效的运动阻滞持续时间(等效边际=3.0 小时)。
360 名接受超声引导锁骨下臂丛神经阻滞的上肢手术患者被随机分配接受 2mg、5mg 或 8mg 无防腐剂的周围神经内注射用甲泼尼龙。所有患者均使用相同的局部麻醉剂(35ml 利多卡因 1%-布比卡因 0.25%加肾上腺素 5μg/ml)。患者和操作者均对甲泼尼龙的剂量不知情。在阻滞过程中,记录操作时间、针数、操作疼痛和并发症(血管穿刺、感觉异常)。随后,一位盲法观察者评估阻滞成功率(定义为 30 分钟时最小感觉运动综合评分达到 14 分中的 16 分)、起效时间以及手术麻醉的发生率(定义为能够完成手术而无需局部浸润、补充阻滞、静脉阿片类药物或全身麻醉)。术后,盲法观察者联系成功阻滞的患者,询问运动阻滞、感觉阻滞和术后镇痛的持续时间。主要观察变量为运动阻滞持续时间。
三组间在技术执行(操作时间/针数/操作疼痛并发症)、起效时间、成功率和手术麻醉方面无差异。此外,三种剂量的甲泼尼龙均提供相似的运动阻滞(14.9-16.1 小时)和感觉阻滞持续时间。虽然 5mg 提供的镇痛持续时间长于 2mg,但差异(2.7 小时)在我们预先设定的等效边际(3.0 小时)内。
2mg、5mg 和 8mg 甲泼尼龙为超声引导锁骨下臂丛神经阻滞提供了临床等效的感觉运动和镇痛持续时间。需要进一步的试验来比较低剂量(即 2mg)和超低剂量(如 0.5-1mg)的周围神经内注射用甲泼尼龙在臂丛神经阻滞中的作用。
TCTR20150624001。